Biotech · Public company · Gaithersburg, MD, US
Emergent BioSolutions Inc.
Ticker EBS · SEC CIK 0001367644
Track this companyFree. Adds Emergent BioSolutions Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials250 recruiting or active
Pipeline programs38From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline38
- ACAM2000Phase 3 · Smallpox Vaccine Adverse ReactionClinicalTrials.gov · fetched Nov 12, 2026
- AV7909Phase 3 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- BioThraxPhase 3 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- hepatitis B vaccinePhase 3 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ACAM2000 Smallpox VaccinePhase 2 · SmallpoxClinicalTrials.gov · fetched Nov 12, 2026
- AIGIV 14.0 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- AIGIV 3.5 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- AIGIV 7.0 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- CiprofloxacinPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Ciprofloxacin 500Mg TabletPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Dose of 1.1 x 10^10 CFU (Cohort 3)Phase 2 · TyphoidClinicalTrials.gov · fetched Nov 12, 2026
- Dose of 5.0 x 10^9 CFU (Cohort 1)Phase 2 · TyphoidClinicalTrials.gov · fetched Nov 12, 2026
- Dose of 7.5 x 10^9 CFU (Cohort 2)Phase 2 · TyphoidClinicalTrials.gov · fetched Nov 12, 2026
- Dose of of 1.7 x 10^10 CFU (Cohort 4)Phase 2 · TyphoidClinicalTrials.gov · fetched Nov 12, 2026
- Doxycycline 100Mg TabletPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Gamunex 180 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Gamunex 360 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Gamunex 90 mg/kgPhase 2 · AnthraxClinicalTrials.gov · fetched Nov 12, 2026
- Vaccinia virus (calf lymph) smallpox vaccine: Dryvax®Phase 2 · SmallpoxClinicalTrials.gov · fetched Nov 12, 2026
- vaccinia virus (calf lymph): DryvaxPhase 2 · SmallpoxClinicalTrials.gov · fetched Nov 12, 2026
- Vaccinia virus: ACAM2000 smallpox vaccinePhase 2 · SmallpoxClinicalTrials.gov · fetched Nov 12, 2026
- 16 mg naloxone AP003Phase 1 · Opioid OverdoseClinicalTrials.gov · fetched Nov 12, 2026
- 8 mg naloxone NARCAN Nasal SprayPhase 1 · Opioid OverdoseClinicalTrials.gov · fetched Nov 12, 2026
- Ad4-H5-VtnPhase 1 · Bird FluClinicalTrials.gov · fetched Nov 12, 2026
- AV7909 Formulation 1Phase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AV7909 Formulation 2Phase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AV7909 Formulation 3Phase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- AV7909 Formulation 4Phase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- BioThraxPhase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Botulinum Antitoxin Heptavalent (A B C D E F G) - (EQUINE)Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Botulism Antitoxin Bivalent (Equine) Types A and BPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Botulism Antitoxin Heptavalent (Equine) Types A-GPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- BrincidofovirPhase 1 · SmallpoxClinicalTrials.gov · fetched Nov 12, 2026
- ControlPhase 1 · Bacillus Anthracis (Anthrax) InfectionClinicalTrials.gov · fetched Nov 12, 2026
- COVID-HIGPhase 1 · SARS-CoV-2 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- COVID-HIGIVPhase 1 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Sanofi Pasteur Influenza Virus Vaccine, H5N1Phase 1 · Bird FluClinicalTrials.gov · fetched Nov 12, 2026
- Stabilized Isoamyl Nitrite (SIAN)Phase 1 · Cyanide PoisoningClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy AdultsPHASE1 · COMPLETED · started May 30, 2023ClinicalTrials.gov NCT05935917 · fetched Nov 12, 2026
- Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 YearsPHASE3 · COMPLETED · started May 12, 2022ClinicalTrials.gov NCT05349617 · fetched Nov 12, 2026
- Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy AdultsPHASE1 · COMPLETED · started Mar 28, 2022ClinicalTrials.gov NCT05377255 · fetched Nov 12, 2026
- Study of SIAN Nasal Spray in Healthy AdultsPHASE1 · COMPLETED · started Dec 21, 2021ClinicalTrials.gov NCT05194358 · fetched Nov 12, 2026
- A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected AdultsPHASE1 · COMPLETED · started Dec 7, 2021ClinicalTrials.gov NCT05142306 · fetched Nov 12, 2026
- A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)PHASE3 · COMPLETED · started Sep 29, 2021ClinicalTrials.gov NCT05072080 · fetched Nov 12, 2026
- A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy AdultsPHASE1 · COMPLETED · started Dec 24, 2020ClinicalTrials.gov NCT04661839 · fetched Nov 12, 2026
- Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)PHASE2 · COMPLETED · started Nov 20, 2019ClinicalTrials.gov NCT03992872 · fetched Nov 12, 2026
- Velocity 2: An Anthrax Vaccine and Antibiotics Clinical StudyPHASE2 · COMPLETED · started Aug 12, 2019ClinicalTrials.gov NCT04067011 · fetched Nov 12, 2026
- VELOCITY: An Anthrax Vaccine Clinical StudyPHASE3 · COMPLETED · started Mar 11, 2019ClinicalTrials.gov NCT03877926 · fetched Nov 12, 2026
- Ciprofloxacin BioThrax Co-Administration StudyPHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01753115 · fetched Nov 12, 2026
- Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy AdultsPHASE3 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01491607 · fetched Nov 12, 2026
- ACAM2000® Myopericarditis RegistryCOMPLETED · started Apr 1, 2011ClinicalTrials.gov NCT01395082 · fetched Nov 12, 2026
- Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy AdultsPHASE1 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01263691 · fetched Nov 12, 2026
- VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIVPHASE3 · COMPLETED · started Sep 13, 2010ClinicalTrials.gov NCT01158157 · fetched Nov 12, 2026
- Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1PHASE1 · COMPLETED · started Oct 1, 2009ClinicalTrials.gov NCT01006798 · fetched Nov 12, 2026
- Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG)PHASE3 · TERMINATED · started Sep 1, 2009ClinicalTrials.gov NCT01311674 · fetched Nov 12, 2026
- Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV)PHASE1_PHASE2 · COMPLETED · started Feb 1, 2009ClinicalTrials.gov NCT00845650 · fetched Nov 12, 2026
- Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)COMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00928577 · fetched Nov 12, 2026
- Safety Surveillance Study of ACAM2000® Vaccinia VaccineCOMPLETED · started Dec 1, 2008ClinicalTrials.gov NCT00927719 · fetched Nov 12, 2026
- Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy AdultsPHASE2 · COMPLETED · started May 1, 2008ClinicalTrials.gov NCT00679172 · fetched Nov 12, 2026
- Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB MusclePHASE1 · COMPLETED · started Feb 1, 2008ClinicalTrials.gov NCT00636519 · fetched Nov 12, 2026
- Safety Study of 7 Botulinum Antitoxin Serotypes Derived From HorsesPHASE1 · COMPLETED · started Jul 1, 2006ClinicalTrials.gov NCT00360737 · fetched Nov 12, 2026
- Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated AdultsPHASE2 · COMPLETED · started Jan 1, 2003ClinicalTrials.gov NCT00053482 · fetched Nov 12, 2026
- Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationPHASE2 · COMPLETED · started Jan 1, 2003ClinicalTrials.gov NCT00053495 · fetched Nov 12, 2026
SEC filings12
- 8-K · 8-K PR 11.4.2026SEC EDGAR · filed Nov 4, 2026 · fetched Nov 12, 2026
- 10-Q · 10-Q 9.30.26SEC EDGAR · filed Nov 3, 2026 · fetched Nov 12, 2026
- 8-K · 8-K ER 11.2.26SEC EDGAR · filed Nov 2, 2026 · fetched Nov 12, 2026
- 8-K · 8-K CFO 10.16.2026SEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 14, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 1, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Apr 30, 2026 · fetched Nov 12, 2026